Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 07:46:00 GMTTonix Pharmaceuticals Announces FDA Alignment on Phase 2 Study Design for TNX-4800 Lyme Disease Prevention Trial - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTMeitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMTSaol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - PR NewswirePR Newswire · Tue, 28 Jul 2026 13:40:00 GMTCorbus Pharmaceuticals Announces FDA Clearance to Initiate - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMTDyne Therapeutics Announces U.S. FDA Clearance of - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 11:30:00 GMTCullinan Therapeutics Announces Positive End-of-Phase 1 - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 11:00:00 GMT